European Real world observational study on Management strategies with Eltrombopag in ITP to detect outcome predictive factors. ERMES
COMMERCIAL POST AUTHORIZATION STUDY
Clinical trial information
- Promoter: NOVARTIS PHARMA AG
- Execution start: 11/06/2021
- End of execution: 30/03/2023